Cancer patients could be disadvantaged by Brexit, say experts

Collaboration with Europe is crucial to future breakthroughs, say cancer experts including Nobel prize winner Sir Paul Nurse

British cancer patients could be left "significantly disadvantaged" by the UK's departure from the EU, leading oncologists have said, as collaboration with European scientists has been vital to making breakthroughs in the field.

In an editorial published on Friday in the ecancermedicalscience journal, six doctors, representing cancer physicians, patient advocacy groups and genomics researchers, said the UK government must be prepared to fill in the gaps in law, regulation and resource allocation that would open up after Brexit.